Noema Pharma adds Darren Carroll and Arthur Franken to Board along with raising CHF54m Series A financing co-led by Sofinnova Partners and Polaris Partners
– SWITZERLAND, Basel – Noema Pharma AG, a Swiss clinical-stage company targeting orphan neurological disorders, today announced it has successfully concluded an oversubscribed Series A CHF54 million financing round co-led by Sofinnova Partners and Polaris Partners alongside a global consortium of new international investors includes Gilde Healthcare, Invus, and BioMed Partners.…